Aminoglycoside Modifying Enzymes

Overview

Journal Drug Resist Updat

Specialties Infectious Diseases
Oncology

Date 2010 Sep 14

PMID 20833577

Citations 545

Authors

Maria S Ramirez

Marcelo E Tolmasky

Affiliations

Soon will be listed here.

Abstract

Aminoglycosides have been an essential component of the armamentarium in the treatment of life-threatening infections. Unfortunately, their efficacy has been reduced by the surge and dissemination of resistance. In some cases the levels of resistance reached the point that rendered them virtually useless. Among many known mechanisms of resistance to aminoglycosides, enzymatic modification is the most prevalent in the clinical setting. Aminoglycoside modifying enzymes catalyze the modification at different -OH or -NH₂ groups of the 2-deoxystreptamine nucleus or the sugar moieties and can be nucleotidyltransferases, phosphotransferases, or acetyltransferases. The number of aminoglycoside modifying enzymes identified to date as well as the genetic environments where the coding genes are located is impressive and there is virtually no bacteria that is unable to support enzymatic resistance to aminoglycosides. Aside from the development of new aminoglycosides refractory to as many as possible modifying enzymes there are currently two main strategies being pursued to overcome the action of aminoglycoside modifying enzymes. Their successful development would extend the useful life of existing antibiotics that have proven effective in the treatment of infections. These strategies consist of the development of inhibitors of the enzymatic action or of the expression of the modifying enzymes.

Citing Articles

The prevalence and distribution of aminoglycoside resistance genes.

Zhang Y, Zhang N, Wang M, Luo M, Peng Y, Li Z Biosaf Health. 2025; 5(1):14-20.

PMID: 40078603 PMC: 11895043. DOI: 10.1016/j.bsheal.2023.01.001.

Molecular Characterization of Aminoglycoside-modifying Enzymes (AMEs)in Aminoglycoside-Resistant : A Cross-sectional Study in Northeastern Iran.

Naderi M, Yousefi Nojookambari N, Talebi S, Mohammadi M, Yazdansetad S Iran J Pathol. 2025; 20(1):118-125.

PMID: 40060226 PMC: 11887641. DOI: 10.30699/ijp.2024.2038509.3342.

Recent advances and challenges in metal-based antimicrobial materials: a review of strategies to combat antibiotic resistance.

Zhu C, Diao Z, Yang Y, Liao J, Wang C, Li Y J Nanobiotechnology. 2025; 23(1):193.

PMID: 40059157 PMC: 11892188. DOI: 10.1186/s12951-025-03249-6.

Exploring molecular mechanisms of drug resistance in bacteria and progressions in CRISPR/Cas9-based genome expurgation solutions.

Vivekanandan K, Kumar P, Jaysree R, Rajeshwari T Glob Med Genet. 2025; 12(2):100042.

PMID: 40051841 PMC: 11883354. DOI: 10.1016/j.gmg.2025.100042.

Evaluation of aminoglycoside- and methicillin-resistant Staphylococcus aureus: phenotypic and genotypic insights from clinical specimens in Ardabil, Iran.

Hushyar S, Doghaheh H, Arzanlou M BMC Infect Dis. 2025; 25(1):285.

PMID: 40016645 PMC: 11869695. DOI: 10.1186/s12879-025-10659-2.

References

Bryan L, van den Elzen H . Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother. 1977; 12(2):163-77. PMC: 429880. DOI: 10.1128/AAC.12.2.163. View

Hou Z, Meng J, Zhao J, Hu B, Liu J, Yan X . Inhibition of beta-lactamase-mediated oxacillin resistance in Staphylococcus aureus by a deoxyribozyme. Acta Pharmacol Sin. 2007; 28(11):1775-82. DOI: 10.1111/j.1745-7254.2007.00646.x. View

Poirel L, Cabanne L, Collet L, Nordmann P . Class II transposon-borne structure harboring metallo-beta-lactamase gene blaVIM-2 in Pseudomonas putida. Antimicrob Agents Chemother. 2006; 50(8):2889-91. PMC: 1538670. DOI: 10.1128/AAC.00398-06. View

Wright G, Thompson P . Aminoglycoside phosphotransferases: proteins, structure, and mechanism. Front Biosci. 1999; 4:D9-21. DOI: 10.2741/wright. View

Culebras E, Martinez J . Aminoglycoside resistance mediated by the bifunctional enzyme 6'-N-aminoglycoside acetyltransferase-2"-O-aminoglycoside phosphotransferase. Front Biosci. 1999; 4:D1-8. DOI: 10.2741/culebras. View

Ferretti J, Gilmore K, Courvalin P . Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two.... J Bacteriol. 1986; 167(2):631-8. PMC: 212936. DOI: 10.1128/jb.167.2.631-638.1986. View

Pansegrau W, Miele L, Lurz R, LANKA E . Nucleotide sequence of the kanamycin resistance determinant of plasmid RP4: homology to other aminoglycoside 3'-phosphotransferases. Plasmid. 1987; 18(3):193-204. DOI: 10.1016/0147-619x(87)90062-x. View

Magnet S, Courvalin P, Lambert T . Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother. 2001; 45(12):3375-80. PMC: 90840. DOI: 10.1128/AAC.45.12.3375-3380.2001. View

Wolf E, Vassilev A, Makino Y, Sali A, Nakatani Y, Burley S . Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase. Cell. 1998; 94(4):439-49. DOI: 10.1016/s0092-8674(00)81585-8. View

10.

Meyer R . Replication and conjugative mobilization of broad host-range IncQ plasmids. Plasmid. 2009; 62(2):57-70. PMC: 2752045. DOI: 10.1016/j.plasmid.2009.05.001. View

11.

Liu M, Haddad J, Azucena E, Kotra L, Kirzhner M, Mobashery S . Tethered bisubstrate derivatives as probes for mechanism and as inhibitors of aminoglycoside 3'-phosphotransferases. J Org Chem. 2000; 65(22):7422-31. DOI: 10.1021/jo000589k. View

12.

White D, Maneewannakul K, von Hofe E, Zillman M, EISENBERG W, Field A . Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs. Antimicrob Agents Chemother. 1998; 41(12):2699-704. PMC: 164191. DOI: 10.1128/AAC.41.12.2699. View

13.

Lambert T, Gerbaud G, Courvalin P . Characterization of the chromosomal aac(6')-Ij gene of Acinetobacter sp. 13 and the aac(6')-Ih plasmid gene of Acinetobacter baumannii. Antimicrob Agents Chemother. 1994; 38(9):1883-9. PMC: 284657. DOI: 10.1128/AAC.38.9.1883. View

14.

Cerda P, Goni P, Millan L, Rubio C, Gomez-Lus R . Detection of the aminoglycosidestreptothricin resistance gene cluster ant(6)-sat4-aph(3 ')-III in commensal viridans group streptococci. Int Microbiol. 2007; 10(1):57-60. View

15.

Levings R, Partridge S, Lightfoot D, Hall R, Djordjevic S . New integron-associated gene cassette encoding a 3-N-aminoglycoside acetyltransferase. Antimicrob Agents Chemother. 2005; 49(3):1238-41. PMC: 549260. DOI: 10.1128/AAC.49.3.1238-1241.2005. View

16.

Murphy E . Nucleotide sequence of a spectinomycin adenyltransferase AAD(9) determinant from Staphylococcus aureus and its relationship to AAD(3") (9). Mol Gen Genet. 1985; 200(1):33-9. DOI: 10.1007/BF00383309. View

17.

Lambert T, Ploy M, Denis F, Courvalin P . Characterization of the chromosomal aac(6')-Iz gene of Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 1999; 43(10):2366-71. PMC: 89484. DOI: 10.1128/AAC.43.10.2366. View

18.

Toriya M, Sakakibara M, Matsushita K, Morohoshi T . Nucleotide sequence of aminoglycoside 6'-N-acetyltransferase [AAC(6')] determinant from Serratia sp. 45. Chem Pharm Bull (Tokyo). 1992; 40(9):2473-7. DOI: 10.1248/cpb.40.2473. View

19.

Magalhaes M, Vetting M, Gao F, Freiburger L, Auclair K, Blanchard J . Kinetic and structural analysis of bisubstrate inhibition of the Salmonella enterica aminoglycoside 6'-N-acetyltransferase. Biochemistry. 2007; 47(2):579-84. PMC: 3084190. DOI: 10.1021/bi701957c. View

20.

Overhage J, Bains M, Brazas M, Hancock R . Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J Bacteriol. 2008; 190(8):2671-9. PMC: 2293252. DOI: 10.1128/JB.01659-07. View